Evidence map›Paper›PMID 24561093›Full record

ArticleNeuroscience letters2014

The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats.

David A Thorn, Chaogui Zhang, Yanan Zhang, Jun-Xu Li

Abstract read
In one paragraph

Article in Neuroscience letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Trace amine-associated receptor 1 and drug abuse.Advances in pharmacology (San Diego, Calif.) · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. TAAR1 and Psychostimulant Addiction.Cellular and molecular neurobiology · 2020
    Review
  10. Article
  11. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David A ThornDepartment of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, the State University of New York, Buffalo, NY 14214, USA.
Chaogui ZhangDepartment of Neurology, University Hospital of Hubei University for Nationalities, Enshi, Hubei 445000,China.
Yanan ZhangResearch Triangle Institute, Research Triangle Park, NC 27709, USA.
Jun-Xu LiDepartment of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, the State University of New York, Buffalo, NY 14214, USA. Electronic address: junxuli@buffalo.edu.

Funding

IMIDAZOLINE I2 RECEPTORS AS TARGETS FOR THE TREATMENT OF PAINR01DA034806 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LI, JUN-XU · 2013 to 2017
$1.7M
Orexin-1 Receptor Ligands for Drug AddictionR33DA032837 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZHANG, YANAN · 2014 to 2015
$992k
Orexin-1 Receptor Ligands for Drug AddictionR21DA032837 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZHANG, YANAN · 2012 to 2013
$519k
Behavioral effects of methamphetamine & imidazoline I2 receptor ligandsR21DA033426 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LI, JUN-XU · 2013 to 2014
$464k
NIDA NIH HHS R01 DA034806NIDA NIH HHS R21 DA032837NIDA NIH HHS R21DA032837NIDA NIH HHS R21 DA033426NIDA NIH HHS R33 DA032837
6 · The paper itself

Abstract

The trace amine associated receptor (TAAR) 1 is a new G protein coupled receptor that critically modulates central dopaminergic system. Recently, several selective TAAR 1 ligands have been described to possess antipsychotic and antidepressant-like activities. However, it is unknown of the role of these ligands in modulating psychostimulant-induced neurobehavioral plasticity. This study examined the effects of a selective TAAR 1 agonist, RO5263397, on cocaine induced behavioral sensitization in rats, a rodent model of drug-induced behavioral plasticity. Daily treatment with 15mg/kg cocaine (i.p., 7 days) induced robust locomotor sensitization in rats. RO5263397 (1-10mg/kg, i.p.) alone did not significantly alter the locomotor activity. Acute treatment with RO5263397 (3.2 and 10mg/kg) did not significantly modify cocaine-induced hyperactivity; however, the induction of locomotor sensitization was significantly blocked after 7 days of daily RO5263397 treatment. More importantly, the expression of locomotor sensitization remained significantly attenuated when rats were re-tested 7 days after the last drug treatment. The marked attenuation of cocaine sensitization was also evidenced by the suppression of the dose-effect function (3.2-32mg/kg) of cocaine sensitization. Together, these data represent the first to report a critical modulatory role of TAAR 1 agonists in cocaine-induced behavioral plasticity, which may be indicative of its potential role for altering other long-lasting behavioral maladaptations of cocaine including drug addiction.

Indexed as

AnimalsCentral Nervous System StimulantsCocaineCocaine-Related DisordersDose-Response Relationship, DrugMaleMotor ActivityRats, Sprague-DawleyReceptors, G-Protein-CoupledTrace Amine-Associated ReceptorsCentral Nervous System StimulantsCocaineReceptors, G-Protein-CoupledTrace Amine-Associated ReceptorsBehavioral sensitizationCocaineRatsTAAR 1

Identifiers

PMID24561093
PMCPMC3991844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.